Founded Year

2015

Stage

Series A | Alive

Total Raised

$4.74M

Last Raised

$4.24M | 3 yrs ago

About Winterlight Labs

WinterLight Labs has developed a technology that aims to quickly and accurately quantify speech and language patterns. With this technology, the company aims to help detect and monitor cognitive and mental diseases such as dementia and Alzheimer's.

Winterlight Labs Headquarter Location

MaRS DD, West Tower 661 University Avenue Suite 1300

Toronto, Ontario, M5G OB7,

Canada

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Winterlight Labs

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Winterlight Labs in 3 CB Insights research briefs, most recently on May 11, 2021.

Expert Collections containing Winterlight Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Winterlight Labs is included in 8 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

M

Medical Devices

8,304 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,232 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.

D

Digital Health

13,070 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,833 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Winterlight Labs Patents

Winterlight Labs has filed 3 patents.

The 3 most popular patent topics include:

  • Classification algorithms
  • Cognitive tests
  • Computational linguistics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/6/2021

Neuropsychological tests, Cognitive tests, Psychological testing, Intelligence, Intelligence tests

Application

Application Date

4/6/2021

Grant Date

Title

Related Topics

Neuropsychological tests, Cognitive tests, Psychological testing, Intelligence, Intelligence tests

Status

Application

Winterlight Labs Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Winterlight Labs Rank

  • When was Winterlight Labs founded?

    Winterlight Labs was founded in 2015.

  • Where is Winterlight Labs's headquarters?

    Winterlight Labs's headquarters is located at MaRS DD, West Tower 661 University Avenue, Toronto.

  • What is Winterlight Labs's latest funding round?

    Winterlight Labs's latest funding round is Series A.

  • How much did Winterlight Labs raise?

    Winterlight Labs raised a total of $4.74M.

  • Who are the investors of Winterlight Labs?

    Investors of Winterlight Labs include Hikma Ventures, First Star Ventures, Grey Sky Venture Partners, Pacific Health Ventures, Novatio Ventures and 5 more.

  • Who are Winterlight Labs's competitors?

    Competitors of Winterlight Labs include Canary Speech, Kintsugi, Ellipsis Health, Neurotrack Technologies, DiamiR, Cognoptix, NeuroLex Laboratories, Darmiyan, NeuroVision Imaging, Modality.AI and 16 more.

You May Also Like

Avalon AI Logo
Avalon AI

Avalon AI uses Machine Learning to build tools for neuroradiologists that automatically measure and help visualize key brain features, enabling more accurate and faster diagnoses of brain diseases. They use the brain scans they collect to facilitate the recruitment of clinical trial patients and accelerate the development of a cure for neurodegenerative diseases like Alzheimer's.

C
Cymedix

Cymedix develops assays for the early detection of mitochondrial diseases such as Alzheimer's disease. Earlier detection enables earlier therapy, and development of personalized medicine solutions.

ADMdx Logo
ADMdx

ADM Diagnostics, dba ADMdx, specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. The company provides pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. The company is developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.

N
NeuroVision Imaging

NeuroVision Imaging is developing retinal imaging technology for early detection and monitoring of Alzheimer's disease.

N
Neurotrack Technologies

Neurotrack is a digital medicine solution for Alzheimer's disease, giving people direct access to the scientifically validated digital diagnostic and therapeutic to delay or prevent memory health conditions.

Darmiyan Logo
Darmiyan

Darmiyan develops fully automated proprietary software that inputs human brain MRIs and produces maps that detect Alzheimer's disease up to fifteen years before symptoms. Its mission is to create a fast, non-invasive, inexpensive, precise, and globally accessible tool for brain health screening and monitoring. Darmiyan's technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.